Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chhavi Rajvanshi"'
Autor:
Simmi Mehra, Aseem Kumar Tiwari, Geet Aggarwal, Swati Pabbi Mehta, Rajni Chauhan, Chhavi Rajvanshi, Deepak Govil
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 65, Iss 1, Pp 111-116 (2022)
Background: Many biomarkers have now been studied such as C-reactive Protein (CRP), procalcitonin (PCT), etc., and are widely used for the diagnosis of sepsis in clinical practice which may determine the appropriate antibiotic treatment. A flowcytome
Externí odkaz:
https://doaj.org/article/0ee3d6dd09a444ffa8a689b843a3c812
Autor:
Rajni Chauhan, Aseem Kumar Tiwari, Chhavi Rajvanshi, Simmi Mehra, Geet Aggarwal, Shyam Bihari Bansal, Vijay Kher
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 2, Pp 99-103 (2021)
Introduction: Pre-transplant compatibility testing involves the use of different methodologies (cell-based and solid phase based) for the determination of anti-human-leukocyte antigen (HLA) antibodies. Implementation of these donor-recipient methods
Externí odkaz:
https://doaj.org/article/0ef805985cc04e90a407bf3273a0e7ae
Autor:
Chhavi Rajvanshi, Aseem K Tiwari, Swati Pabbi, Geet Aggarwal, Abhishek Saini, Rajni Chauhan, Simmi Mehra, Poonam Kumari
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 3, Pp 279-281 (2021)
Pre-transplant compatibility work-up has evolved tremendously from conventional CDC only to CDC with more sensitive FCXM testing with bead-based assays (LMX and SAB). Detection of alloantibodies is one of the major objective in work-up algorithm. Con
Externí odkaz:
https://doaj.org/article/552981d9ff0f435d9cdcb5c2ac713e07
Publikováno v:
Global Journal of Transfusion Medicine, Vol 4, Iss 2, Pp 224-226 (2019)
Introduction: Hepatitis C virus infects 3% people globally, that causes significant morbidity and mortality. For diagnosis and monitoring of treatment of HCV infection; biochemical markers and HCV RNA are tested. Aim of the Study: We tried to find ou
Externí odkaz:
https://doaj.org/article/48a461dfcacd49a08ee787fa22b3088c
Autor:
Simmi Mehra, Aseem Kumar Tiwari, Chhavi Rajvanshi, Rajni Chauhan, Randhir Sud, Arvinder Singh Soin
Publikováno v:
Global Journal of Transfusion Medicine, Vol 6, Iss 1, Pp 65-0 (2021)
Background and Objectives: In addition, the role of human leukocyte antigen (HLA) in transplantation, importance of HLA in disease susceptibility, and protection has been widely studied. The aim of the present study was to find out the HLA allelic fr
Externí odkaz:
https://doaj.org/article/15c70b32021945cd9b0361d16286f89d
Autor:
Simmi Mehra, Vijay Kher, Shyam Bihari Bansal, Geet Aggarwal, Aseem K Tiwari, Rajni Chauhan, Chhavi Rajvanshi
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 2, Pp 99-103 (2021)
Introduction: Pre-transplant compatibility testing involves the use of different methodologies (cell-based and solid phase based) for the determination of anti-human-leukocyte antigen (HLA) antibodies. Implementation of these donor-recipient methods
Autor:
Chhavi, Rajvanshi, Aseem K, Tiwari, Swati, Pabbi, Geet, Aggarwal, Simmi, Mehra, Rajni, Chauhan, Dheeraj, Gautam, Ashok Kumar, Vaid
Publikováno v:
Indian journal of cancer. 58(2)
Autor:
Simmi, Mehra, Aseem Kumar, Tiwari, Swati Pabbi, Mehta, Ritesh, Sachdev, Chhavi, Rajvanshi, Rajni, Chauhan, Abhishek, Saini, Ashok, Vaid
Publikováno v:
Indian journal of cancer. 59(2)
The requirement for the mutation analysis for Kirsten rat sarcoma viral oncogene (KRAS) in colorectal cancer (CRC) is rapidly increasing as it is a predictive biomarker and also, its absence signifies response to anti-epidermal growth factor receptor
Publikováno v:
Indian Journal of Nephrology, Vol 30, Iss 1, Pp 57-58 (2020)
Indian Journal of Nephrology
Indian Journal of Nephrology
Autor:
Geet Aggarwal, Simmi Mehra, Shoma Paul Nandi, Vijay Kher, Shyam Bihari Bansal, Chhavi Rajvanshi, Rajni Chauhan, Abhishek Saini, Aseem K Tiwari
Publikováno v:
Indian Journal of Nephrology
Introduction: Solid organ transplantation is the preferred therapeutic modality of treatment in patients affected by terminal organ failures. Human leukocyte antigens (HLAs) plays an important role in graft survival. In many of the cases of rejection